31.40
price down icon8.96%   -3.09
after-market After Hours: 31.21 -0.19 -0.61%
loading
Liquidia Corp stock is traded at $31.40, with a volume of 2.88M. It is down -8.96% in the last 24 hours and up +1.98% over the past month. Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
See More
Previous Close:
$34.49
Open:
$34.54
24h Volume:
2.88M
Relative Volume:
1.48
Market Cap:
$2.73B
Revenue:
$19.32M
Net Income/Loss:
$-141.47M
P/E Ratio:
-18.63
EPS:
-1.6851
Net Cash Flow:
$-120.48M
1W Performance:
-8.75%
1M Performance:
+1.98%
6M Performance:
+160.36%
1Y Performance:
+159.50%
1-Day Range:
Value
$30.76
$34.88
1-Week Range:
Value
$30.76
$35.24
52-Week Range:
Value
$11.26
$36.41

Liquidia Corp Stock (LQDA) Company Profile

Name
Name
Liquidia Corp
Name
Phone
919.328.4400
Name
Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Name
Employee
170
Name
Twitter
@Liquidia_Inc
Name
Next Earnings Date
2025-03-19
Name
Latest SEC Filings
Name
LQDA's Discussions on Twitter

Compare LQDA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
LQDA
Liquidia Corp
31.40 3.00B 19.32M -141.47M -120.48M -1.6851
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.13 115.03B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
776.31 81.12B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
400.17 52.54B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
839.99 51.78B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
177.12 37.12B 447.02M -1.18B -906.14M -6.1812

Liquidia Corp Stock (LQDA) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-20-25 Initiated Wells Fargo Overweight
Aug-15-25 Resumed Jefferies Buy
May-19-25 Downgrade Oppenheimer Perform → Underperform
Dec-20-24 Initiated Wells Fargo Overweight
Oct-16-24 Initiated Scotiabank Sector Outperform
Aug-19-24 Upgrade Raymond James Outperform → Strong Buy
Aug-16-24 Initiated Raymond James Outperform
Jun-25-24 Initiated Oppenheimer Perform
Jan-05-24 Reiterated Needham Buy
Sep-19-22 Resumed Wedbush Underperform
Sep-01-22 Downgrade Wedbush Neutral → Underperform
Jul-22-22 Initiated Ladenburg Thalmann Buy
May-31-22 Initiated BTIG Research Buy
May-26-22 Initiated BofA Securities Buy
Dec-04-20 Initiated H.C. Wainwright Buy
Nov-20-20 Downgrade Wedbush Outperform → Neutral
Nov-08-18 Resumed Jefferies Buy
Sep-05-18 Initiated Wedbush Outperform
Aug-20-18 Initiated Jefferies Buy
Aug-20-18 Initiated Needham Buy
View All

Liquidia Corp Stock (LQDA) Latest News

pulisher
Jan 03, 2026

Liquidia (LQDA) stock slides after heavy $30 put bets—what investors are watching next - ts2.tech

Jan 03, 2026
pulisher
Jan 03, 2026

Liquidia Corporation (NASDAQ:LQDA) Has Found A Path To Profitability - 富途牛牛

Jan 03, 2026
pulisher
Jan 02, 2026

Liquidia stock drops 8% today as put-option hedging spikes — what’s next for LQDANEW YORK, Jan 2, 2026, 14:24 ET — Regular session - ts2.tech

Jan 02, 2026
pulisher
Jan 02, 2026

Stock Traders Purchase Large Volume of Liquidia Put Options (NASDAQ:LQDA) - MarketBeat

Jan 02, 2026
pulisher
Jan 02, 2026

Liquidia (LQDA) Shares Decline Amid Market Movement - GuruFocus

Jan 02, 2026
pulisher
Jan 02, 2026

Liquidia (NASDAQ:LQDA) Trading Down 5.6%Time to Sell? - MarketBeat

Jan 02, 2026
pulisher
Dec 27, 2025

Liquidia Corporation (NASDAQ:LQDA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 27, 2025
pulisher
Dec 26, 2025

Liquidia (LQDA) Receives Reiterated 'Buy' Rating from BTIG Analy - GuruFocus

Dec 26, 2025
pulisher
Dec 26, 2025

LQDA FinancialsIncome Statement - Quiver Quantitative

Dec 26, 2025
pulisher
Dec 26, 2025

Liquidia (NASDAQ:LQDA) Receives "Buy" Rating from BTIG Research - MarketBeat

Dec 26, 2025
pulisher
Dec 25, 2025

Assessing Liquidia (LQDA) Valuation After Bullish Analyst Reaffirmations and YUTREPIA Patent Uncertainty - simplywall.st

Dec 25, 2025
pulisher
Dec 24, 2025

Liquidia Fails to Escape UTC Patent Suit Over Lung Drug Yutrepia - Bloomberg Law News

Dec 24, 2025
pulisher
Dec 24, 2025

February 2026 Options Now Available For Liquidia (LQDA) - Nasdaq

Dec 24, 2025
pulisher
Dec 22, 2025

How Liquidia’s Reaffirmed Analyst Support and Revenue Momentum Will Impact Liquidia (LQDA) Investors - simplywall.st

Dec 22, 2025
pulisher
Dec 22, 2025

Liquidia Technologies stock hits 52-week high at 35.55 USD By Investing.com - Investing.com Canada

Dec 22, 2025
pulisher
Dec 22, 2025

Liquidia Technologies stock hits 52-week high at 35.55 USD - Investing.com

Dec 22, 2025
pulisher
Dec 21, 2025

Liquidia (LQDA) Climbs 10.7%, Nears 52-Week High on Strong Demand for Heart Treatment - MSN

Dec 21, 2025
pulisher
Dec 20, 2025

Can Liquidia Corporation stock sustain free cash flow growthWeekly Stock Analysis & Community Consensus Trade Signals - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

How Liquidia Corporation stock reacts to Fed rate cuts2025 Bull vs Bear & High Yield Stock Recommendations - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Breakouts Watch: Can Liquidia Corporation (LT4) stock sustain breakout momentumJuly 2025 Retail & Free Technical Pattern Based Buy Signals - ulpravda.ru

Dec 19, 2025
pulisher
Dec 19, 2025

How Liquidia Corporation stock performs in weak economyStop Loss & Weekly High Return Stock Forecasts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Can Liquidia Corporation stock deliver surprise earnings beatJuly 2025 Reactions & Free Fast Entry Momentum Trade Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 18, 2025

Will Liquidia Corporation (LT4) stock sustain bullish trend into 2025Dip Buying & Verified Momentum Stock Alerts - Улправда

Dec 18, 2025
pulisher
Dec 16, 2025

Is It Too Late To Consider Liquidia After Its 182.6% 2025 Surge? - simplywall.st

Dec 16, 2025
pulisher
Dec 16, 2025

Is It Too Late to Consider Liquidia After Its 1,051% Five Year Surge? - Yahoo Finance

Dec 16, 2025
pulisher
Dec 15, 2025

Take the Zacks Approach to Beat the Markets: Liquidia, Western Digital & Johnson & Johnson in Focus - Yahoo Finance

Dec 15, 2025
pulisher
Dec 14, 2025

Reassessing Liquidia (LQDA) Valuation After Yutrepia’s Strong Launch and Growing Institutional Confidence - simplywall.st

Dec 14, 2025
pulisher
Dec 13, 2025

AWH Capital L.P. Takes $866,000 Position in Liquidia Corporation $LQDA - MarketBeat

Dec 13, 2025
pulisher
Dec 11, 2025

Arquitos Capital Management’s Updates on Liquidia Corporation (LQDA) - Yahoo Finance

Dec 11, 2025
pulisher
Dec 11, 2025

HighVista Strategies LLC Sells 82,869 Shares of Liquidia Corporation $LQDA - MarketBeat

Dec 11, 2025
pulisher
Dec 10, 2025

Velan Capital Investment Management LP Cuts Stock Position in Liquidia Corporation $LQDA - MarketBeat

Dec 10, 2025
pulisher
Dec 09, 2025

Liquidia (NASDAQ:LQDA) Hits New 12-Month HighShould You Buy? - MarketBeat

Dec 09, 2025
pulisher
Dec 08, 2025

Pale Fire Capital SE Invests $1.07 Million in Liquidia Corporation $LQDA - MarketBeat

Dec 08, 2025
pulisher
Dec 06, 2025

Liquidia Corporation (NASDAQ:LQDA) Looks Just Right With A 30% Price Jump - simplywall.st

Dec 06, 2025
pulisher
Dec 05, 2025

Assessing Liquidia (LQDA) Valuation After Strong Q3 Earnings Beat and Surging Yutrepia Sales - simplywall.st

Dec 05, 2025
pulisher
Dec 05, 2025

Stonepine Capital Management LLC Invests $623,000 in Liquidia Corporation $LQDA - MarketBeat

Dec 05, 2025
pulisher
Dec 04, 2025

How Liquidia Corporation stock compares to industry benchmarksJuly 2025 Patterns & Fast Entry and Exit Trade Plans - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Why Liquidia Corporation (LT4) stock is trending on social mediaWeekly Investment Summary & Growth Oriented Trade Recommendations - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will Liquidia Corporation (LT4) stock outperform small cap peers2025 Retail Activity & Low Drawdown Trading Techniques - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

What analysts say about Liquidia Corporation LT4 stockMoving Average Strategies & Beat the Market With Predictive Algorithms - earlytimes.in

Dec 03, 2025
pulisher
Dec 03, 2025

Michael Kaseta Sells 1,166 Shares of Liquidia (NASDAQ:LQDA) Stock - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Liquidia (NASDAQ:LQDA) Insider Jason Adair Sells 693 Shares - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Liquidia (NASDAQ:LQDA) General Counsel Sells $34,507.68 in Stock - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Liquidia (NASDAQ:LQDA) Insider Scott Moomaw Sells 831 Shares - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Liquidia Technologies stock hits 52-week high at 32.96 USD - Investing.com

Dec 03, 2025
pulisher
Dec 03, 2025

Liquidia Technologies stock hits 52-week high at 32.96 USD By Investing.com - Investing.com Canada

Dec 03, 2025
pulisher
Dec 03, 2025

LQDA SEC FilingsLiquidia Corporation 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 03, 2025
pulisher
Dec 02, 2025

Liquidia corp general counsel sells $34507 in LQDA stock By Investing.com - Investing.com South Africa

Dec 02, 2025
pulisher
Dec 02, 2025

Liquidia corp general counsel sells $34507 in LQDA stock - Investing.com

Dec 02, 2025
pulisher
Dec 02, 2025

Officer Adair Acquires 870 Of Liquidia Corp [LQDA] - TradingView

Dec 02, 2025
pulisher
Dec 02, 2025

Virtus Investment Advisers LLC Has $81,000 Position in Liquidia Corporation $LQDA - MarketBeat

Dec 02, 2025

Liquidia Corp Stock (LQDA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$38.86
price up icon 0.57%
$31.82
price up icon 3.31%
$101.42
price up icon 2.68%
$96.69
price up icon 1.57%
biotechnology ONC
$311.02
price up icon 2.37%
$177.12
price up icon 1.77%
Cap:     |  Volume (24h):